Both TLR4 and HO-1 activity inhibition prevent BTZ-dependent IRE1, PERK, BiP, and CHOP upregulation, suggesting that TLR4 utilizes UPR signaling under basal and BTZ-induced ER stress conditions to promote MM survival. Here, TLR4 is linked to Miyoshi myopathy.